Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop

In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-dependent insulinotropic polypeptide receptor agonist (GIP RA)/glucagon-like peptide-1 recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceriello, Antonio, Rodbard, Helena W., Battelino, Tadej, Brosius, Frank, Cosentino, Francesco, Green, Jennifer, Ji, Linong, Kellerer, Monika, Koob, Susan, Kosiborod, Mikhail, Lalic, Nebojsa, Marx, Nikolaus, Nedungadi, T. Prashant, Parkin, Christopher G., Rydén, Lars, Sheu, Wayne Huey-Herng, Standl, Eberhard, Vandvik, Per Olav, Schnell, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576408/
https://www.ncbi.nlm.nih.gov/pubmed/37833776
http://dx.doi.org/10.1186/s12933-023-01993-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576408/
https://www.ncbi.nlm.nih.gov/pubmed/37833776
http://dx.doi.org/10.1186/s12933-023-01993-3

Ejemplares similares